1-deoxynojirimycin has been researched along with Blood Poisoning in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, W; Jiang, L; Li, XY; Liu, J; Lu, L; Shi, H; Wang, X; Yang, J; Yu, S; Zhai, M; Zhang, L; Zhu, H | 1 |
| Dwek, RA; Hill, ML; Martinez, FO; Miller, JL; Perera, N; Sayce, AC; Tyrrell, BE; Zitzmann, N | 1 |
2 other study(ies) available for 1-deoxynojirimycin and Blood Poisoning
| Article | Year |
|---|---|
1-Deoxynojirimycin attenuates septic cardiomyopathy by regulating oxidative stress, apoptosis, and inflammation via the JAK2/STAT6 signaling pathway.
Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Apoptosis; Cardiomyopathies; Cytokines; Heart Diseases; Hypoglycemic Agents; Inflammation; Janus Kinase 2; Janus Kinases; Lipopolysaccharides; Mice; Oxidative Stress; Reactive Oxygen Species; Sepsis; Signal Transduction | 2022 |
Pathogen-induced inflammation is attenuated by the iminosugar MON-DNJ via modulation of the unfolded protein response.
Topics: 1-Deoxynojirimycin; Anti-Inflammatory Agents; Antigens, Fungal; Cells, Cultured; Cytokines; Dengue Virus; Endoplasmic Reticulum; Host-Pathogen Interactions; Humans; Inflammation; Lipopolysaccharides; Macrophages; Primary Cell Culture; Sepsis; Toll-Like Receptor 4; Unfolded Protein Response | 2021 |